Neetu Chandra Sharma is a National Writer- Health at Mint. She focuses on themes related to medicine and healthcare, including the healthcare system, alternative medicine, diagnostics, and health and wellness, particularly in the context of India and its business landscape. Neetu's work has been featured in Business Today.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
India (National)
Not enough data
Neetu Chandra Sharma's coverage primarily focuses on the healthcare and pharmaceutical industry in India. She frequently includes data, press releases, government announcements, and private sector developments in her articles. To effectively reach out to Neetu Chandra Sharma, consider offering access to exclusive data or insights related to the Indian healthcare sector. Additionally, pitches that provide analysis of government policies or initiatives impacting healthcare or pharmaceuticals in India are likely to resonate with her coverage focus.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Neetu Chandra Sharma
In a trial, participants using Zepbound reportedly lost an average of 20.2% of their body weight
By: Neetu Chandra Sharma
Ameera Shah, Promoter and Executive Chairperson of Metropolis Healthcare, discussed the growth potential of the Indian oncology market, and the need for advanced cancer testing.
By: Neetu Chandra Sharma
The Rs 246.8 crore deal includes 55% financing in cash and 45% through an equity swap.
By: Neetu Chandra Sharma
Priced from Rs 599 to Rs 10,000, LightLife includes a starter pack for first-time users and a 100-day plan with consultations.
By: Neetu Chandra Sharma
Tirzepatide had received approval in a single-dose prefilled pen format in January 2024 for use as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes, provided the company conducts a Phase IV clinical trial in India
By: Neetu Chandra Sharma
The global neoliberal order, once characterised by multilateral institutions and free trade, is now widely considered over. This transition marks a shift to a world where nationalistic policies such as "America First," "India First," "China First," and "Europe First" gain momentum, David Bach, President and Nestlé Professor at IMD Business School, Switzerland said.
By: Neetu Chandra Sharma
India is undergoing a digital transformation with initiatives like Digital India and Startup India, alongside advancements in e-commerce, AI, and telemedicine.
By: Neetu Chandra Sharma
While Indian pharma companies could gain a competitive edge in the US market, the move may disrupt the medical device supply chain and drive-up costs for Indian firms exporting such products.
By: Neetu Chandra Sharma
The past year has been eventful for the Indian pharma sector, with some companies witnessing growth, and some challenges. The outlook for the sector, however, remains positive - Issue Date: Dec 22, 2024
By: Neetu Chandra Sharma
Under her leadership, Piramal Pharma has scaled new heights, blending agility and a patient-first approach to thrive in a dynamic industry.
(833) 317-6278 
